CONCLUSIONS Probiotic consumption may improve glycemic control modestly .
Modification of gut microbiota by probiotic supplementation may be a method for preventing and control hyperglycemia in clinical practice
BACKGROUND Previous clinical trials indicate that probiotic consumption may improve blood glucose control , however , results from r and omized trials on glycemic control have been inconsistent .
OBJECTIVE To investigate the effects of probiotics on glycemic control in a systematic review and meta- analysis of r and omized controlled trials .
Effect of Lactobacillus gasseri BNR17 on Overweight and Obese Adults: A Randomized, Double-Blind Clinical Trial
Background Lactobacillus gasseri BNR17 is a type of probiotic strain isolated from human breast milk . A study was reported regarding the fact that BNR17 was an inhibitor of obesity and diabetic activities in the human body through previous animal experiments . This study was furthered to investigate the effect of BNR17 , a probiotic strain isolated from human breast milk , on obese and overweight adults . Methods Sixty-two obese volunteers aged 19 to 60 with body mass index ≥ 23 kg/m2 and fasting blood sugar ≥ 100 mg/dL participated in a placebo controlled , r and omized , and double-blind trial . For 12 weeks , 57 participants were given either placebo or BNR17 and were tested by measuring body fat , body weight , various biochemical parameters , vital signs , and computed tomography at the start of the study and at weeks 4 , 8 , and 12 . The subjects assumed usual daily activities without having to make behavioral or dietary modifications during the course of the study . Results At the 12th week , a slight reduction in body weight was noted in the BNR17 group , but there were no significant weight changes between groups . Decrease of waist and hip circumferences in the BNR17 group was more pronounced than those in the placebo group . The two groups had no special or severe adverse reactions . Conclusion Despite there being no change in behavior or diet , administration of only the supplement of BNR17  reduced weight and waist and hip circumference . However , there were no significant differences between the two groups . These findings warrant a subsequent longer-term prospect i ve clinical investigation with a large population
CONCLUSIONS Probiotic consumption may improve glycemic control modestly .
Modification of gut microbiota by probiotic supplementation may be a method for preventing and control hyperglycemia in clinical practice
BACKGROUND Previous clinical trials indicate that probiotic consumption may improve blood glucose control , however , results from r and omized trials on glycemic control have been inconsistent .
OBJECTIVE To investigate the effects of probiotics on glycemic control in a systematic review and meta- analysis of r and omized controlled trials .